FR2088019A1 - Esters of 2 and 6-substituted nicotinic acids - with vasomotor active - Google Patents

Esters of 2 and 6-substituted nicotinic acids - with vasomotor active

Info

Publication number
FR2088019A1
FR2088019A1 FR7016802A FR7016802A FR2088019A1 FR 2088019 A1 FR2088019 A1 FR 2088019A1 FR 7016802 A FR7016802 A FR 7016802A FR 7016802 A FR7016802 A FR 7016802A FR 2088019 A1 FR2088019 A1 FR 2088019A1
Authority
FR
France
Prior art keywords
active
vasomotor
esters
nicotinic acids
substituted nicotinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7016802A
Other languages
French (fr)
Other versions
FR2088019B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RABOT ETS DAVID
Original Assignee
RABOT ETS DAVID
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RABOT ETS DAVID filed Critical RABOT ETS DAVID
Priority to FR7016802A priority Critical patent/FR2088019A1/en
Priority to GB1249771A priority patent/GB1352415A/en
Priority to BE766808A priority patent/BE766808A/en
Priority to ES71390924A priority patent/ES390924A1/en
Publication of FR2088019A1 publication Critical patent/FR2088019A1/en
Application granted granted Critical
Publication of FR2088019B1 publication Critical patent/FR2088019B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3

Abstract

Cpds. are of formula: (where R is aliphatic, araliphatic, heteroaliphatic or aminoalkyl; R2 and R6 = opt. substd. 1-20C aliphatic gps., alkenylaromatic, alkenylheterocyclic, alklaromatic, alkylheterocyclic. Prefd. gps. R are -A.B where B is dimethylamino, diethylamino, pyrrolidino, piperidino, hexamethyleneimino, morpholino, piperazino, N-methylpiperazino; A is -CH2-CH2- or -CH2.CH2-CH2-). Cpds. have vasomotor activity, active in animals at parenteral doses of 10 mg/kg.
FR7016802A 1970-05-03 1970-05-08 Esters of 2 and 6-substituted nicotinic acids - with vasomotor active Granted FR2088019A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR7016802A FR2088019A1 (en) 1970-05-08 1970-05-08 Esters of 2 and 6-substituted nicotinic acids - with vasomotor active
GB1249771A GB1352415A (en) 1970-05-03 1971-04-30 Esters of substituted nicotine acids
BE766808A BE766808A (en) 1970-05-03 1971-05-06 NEW ESTERS OF SUBSTITUTE NICOTINIC ACID
ES71390924A ES390924A1 (en) 1970-05-03 1971-05-06 Esters of substituted nicotine acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7016802A FR2088019A1 (en) 1970-05-08 1970-05-08 Esters of 2 and 6-substituted nicotinic acids - with vasomotor active

Publications (2)

Publication Number Publication Date
FR2088019A1 true FR2088019A1 (en) 1972-01-07
FR2088019B1 FR2088019B1 (en) 1974-08-30

Family

ID=9055254

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7016802A Granted FR2088019A1 (en) 1970-05-03 1970-05-08 Esters of 2 and 6-substituted nicotinic acids - with vasomotor active

Country Status (1)

Country Link
FR (1) FR2088019A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2205515A1 (en) * 1972-11-08 1974-05-31 Hokuriku Pharmaceutical
US7199140B2 (en) 2001-06-26 2007-04-03 Astrazeneca Ab Vinyl phenyl derivatives as GLK activators
US7390908B2 (en) 2001-08-17 2008-06-24 Astrazeneca Ab Compounds effecting glucokinase
US7642259B2 (en) 2005-07-09 2010-01-05 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US7696191B2 (en) 2006-12-21 2010-04-13 Astrazeneca Ab Crystalline compound
US7700640B2 (en) 2004-10-16 2010-04-20 Astrazeneca Ab Process for making phenoxy benzamide compounds
US7709505B2 (en) 2002-11-19 2010-05-04 Astrazeneca Ab Benzofuran derivatives, process for their preparation and intermediates thereof
US7902200B2 (en) 2006-10-23 2011-03-08 Astrazeneca Ab Chemical compounds
US7973178B2 (en) 2005-11-28 2011-07-05 Astrazeneca Ab Chemical process for the preparation of an amido-phenoxybenzoic acid compound
US8071608B2 (en) * 2009-04-09 2011-12-06 Astrazeneca Ab Therapeutic agents

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200600086A (en) 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
TW200714597A (en) 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
SA07280576B1 (en) 2006-10-26 2011-06-22 استرازينيكا ايه بي Benzoyl amino heterocyclyl compounds as glucokinase (GLK) activators
MX2011001333A (en) 2008-08-04 2011-03-15 Astrazeneca Ab Pyrazolo [3,4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity.
GB0902406D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
GB0902434D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
WO2010116177A1 (en) 2009-04-09 2010-10-14 Astrazeneca Ab A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH458344A (en) * 1964-01-20 1968-06-30 Orgamol Sa Process for the preparation of basic esters of pyridine carboxylic acids
JPS644086A (en) * 1987-06-26 1989-01-09 Yokogawa Electric Corp Quantum resistance standard

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH458344A (en) * 1964-01-20 1968-06-30 Orgamol Sa Process for the preparation of basic esters of pyridine carboxylic acids
JPS644086A (en) * 1987-06-26 1989-01-09 Yokogawa Electric Corp Quantum resistance standard

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2205515A1 (en) * 1972-11-08 1974-05-31 Hokuriku Pharmaceutical
US7199140B2 (en) 2001-06-26 2007-04-03 Astrazeneca Ab Vinyl phenyl derivatives as GLK activators
US7390908B2 (en) 2001-08-17 2008-06-24 Astrazeneca Ab Compounds effecting glucokinase
US7524957B2 (en) 2001-08-17 2009-04-28 Astrazeneca Ab Compounds effecting glucokinase
US7951830B2 (en) 2001-08-17 2011-05-31 Astrazeneca Ab Compounds effecting glucokinase
US7709505B2 (en) 2002-11-19 2010-05-04 Astrazeneca Ab Benzofuran derivatives, process for their preparation and intermediates thereof
US7700640B2 (en) 2004-10-16 2010-04-20 Astrazeneca Ab Process for making phenoxy benzamide compounds
US7642259B2 (en) 2005-07-09 2010-01-05 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US7642263B2 (en) 2005-07-09 2010-01-05 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US7977328B2 (en) 2005-07-09 2011-07-12 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US7973178B2 (en) 2005-11-28 2011-07-05 Astrazeneca Ab Chemical process for the preparation of an amido-phenoxybenzoic acid compound
US7902200B2 (en) 2006-10-23 2011-03-08 Astrazeneca Ab Chemical compounds
US7696191B2 (en) 2006-12-21 2010-04-13 Astrazeneca Ab Crystalline compound
US8071608B2 (en) * 2009-04-09 2011-12-06 Astrazeneca Ab Therapeutic agents

Also Published As

Publication number Publication date
FR2088019B1 (en) 1974-08-30

Similar Documents

Publication Publication Date Title
FR2088019A1 (en) Esters of 2 and 6-substituted nicotinic acids - with vasomotor active
ES406084A2 (en) Derivatives of 5-cinnamoyl benzofuran
CA1016414A (en) Fluidized bed furnace having fuel air supply lance and a fuel air supply lance construction
GB1380219A (en) Latch needle for knitting machines
GB1251282A (en)
GB1294343A (en) A patterning mechanism in a multi-feed circular knitting machine
PH10188A (en) 6-(l-3-acylamidoacetamido)-penicillanic acids,their pharmaceutically acceptable salts and their medicinal uses
FR2088020A1 (en) Aminoalkyl esters of diacetylgentisic acid - with analgesic activity
FR2166101A1 (en) 1,4-di (morpholino,piperidino or pyrrolidino)-7-substd - -pyrido (3,4-d)-pyridazines - as diuretics
FR2100973A1 (en) 5-Aminopyrazoles - with analgesic, antiinflammatory and muscle relaxant activity
GB1457005A (en) 2-substituted-3-aminoquinoxalines
FR2088018A1 (en) Vasodilatory, substd nicotinic acid amino ester derivs
FR2073427A1 (en) 4-methyl-5-ethyl-n-heterocyclic thiazoles - with antianoxic activity
GB1396465A (en) 1-arylideneamino-4-2-oxo-3-phenyl-3-benzofuryl piperazines
GB1389186A (en) Chromone derivatives processes for their manufacture
FR2154082A5 (en) Antiarrhythmic piperazine derivs prepn - from benzhydrylpiperazine cinnamaldehyde by leuckart reactn
ES385522A1 (en) Azamorphinan compounds
FR2085647A1 (en) 6-amino-2-methyl-2-heptanols - with cardiovascular analeptic analgesic and spasmolytic activity
GB1344104A (en) Cams for knitting machines
FR2068430A1 (en) 3-dialkylaminoalkoxy coumarilonitriles vasodilatory spasmolytic
FR2182886A1 (en) 5-aminoalkyl-tetrahydro-1,5-benzoxazepines - as cns-depressants from tetrahydrobenzo xazepines via 5-chloroacyl-derivs with amines
FR2150240A2 (en) 5-cinnamoyl-4,7-dimethoxy-6-tertiary amino alkyl - -benzofurans - vasodilators,hypotensives,diuretics,spasmolytics,analg
USD232090S (en) Portable hydrant
FR2192807A2 (en) 5-cinnamoyl-4,7-dimethoxy-6-tertiary amino alkyl - -benzofurans - vasodilators,hypotensives,diuretics,spasmolytics,analg
YU263971A (en) Improvement in a head for final treatment of deep cylindrical openings by simultaneously turning and rolling

Legal Events

Date Code Title Description
ST Notification of lapse